Literature DB >> 22863723

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.

J Pidala1, J Kim, M Schell, S J Lee, R Hillgruber, V Nye, E Ayala, M Alsina, B Betts, R Bookout, H F Fernandez, T Field, F L Locke, T Nishihori, J L Ochoa, L Perez, J Perkins, J Shapiro, C Tate, M Tomblyn, C Anasetti.   

Abstract

Factors relevant to finding a suitable unrelated donor and barriers to effective transplant utilization are incompletely understood. Among a consecutive series of unrelated searches (n=531), an 8/8 HLA-A, -B, -C and -DRB1-matched unrelated donor was available for 289 (54%) patients, 7/8 for 159 (30%) and no donor for 83 (16%). Patients of Caucasian race (P<0.0001) were more likely to find a donor. Younger age (P=0.01), Caucasian race (P=0.03), lower CIBMTR (Center for International Blood and Marrow Transplantation Research) risk (P=0.005), and 8/8 HLA matching (P=0.005) were associated with higher odds of reaching hematopoietic cell transplantation (HCT). In a univariate analysis of OS, finding a donor was associated with hazard ratio (HR) of 0.85 (95% CI 0.63-1.2), P=0.31. Karnofsky performance status (KPS) accounted for interaction between having a donor and survival. Patients with KPS 90-100 and a donor had significantly reduced hazard for death (HR 0.59, 95% CI 0.38-0.90, P=0.02). These data provide estimates of the probability to find an unrelated donor in the era of high-resolution HLA typing, and identify potentially modifiable barriers to reaching HCT. Further efforts are needed to enhance effective donor identification and transplant utilization, particularly in non-Caucasian ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863723      PMCID: PMC4500122          DOI: 10.1038/bmt.2012.150

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  23 in total

1.  Comorbidity and beyond: pre-transplant clinical assessment.

Authors:  A S Artz
Journal:  Bone Marrow Transplant       Date:  2005-09       Impact factor: 5.483

2.  Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.

Authors:  Andrew S Artz; Daniel A Pollyea; Masha Kocherginsky; Wendy Stock; Elizabeth Rich; Olatoyosi Odenike; Todd Zimmerman; Sonali Smith; Lucy Godley; Michael Thirman; Christopher Daugherty; Martine Extermann; Richard Larson; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2006-09       Impact factor: 5.742

3.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

4.  Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

Authors:  K Scott Baker; Fausto R Loberiza; Hongmei Yu; Mitchell S Cairo; Brian J Bolwell; Willem A Bujan-Boza; Bruce M Camitta; Juan Jose Garcia; Winston G Ho; Jane L Liesveld; Dipnarine Maharaj; David I Marks; Kirk R Schultz; Peter Wiernik; Axel R Zander; Mary M Horowitz; Armand Keating; Daniel J Weisdorf
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

5.  Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.

Authors:  Francesco Frassoni; Francesca Gualandi; Marina Podestà; Anna Maria Raiola; Adalberto Ibatici; Giovanna Piaggio; Mario Sessarego; Nadia Sessarego; Marco Gobbi; Nicoletta Sacchi; Myriam Labopin; Andrea Bacigalupo
Journal:  Lancet Oncol       Date:  2008-08-08       Impact factor: 41.316

6.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

7.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

8.  Patient socioeconomic status as a prognostic factor for allo-SCT.

Authors:  L Silla; G B Fischer; A Paz; L E Daudt; I Mitto; B Katz; M da Graça Grossini; H N Bittencourt; A Jochims; L Fogliatto; C M Bittar; J R Friedrisch; R I Bittencourt
Journal:  Bone Marrow Transplant       Date:  2008-11-03       Impact factor: 5.483

Review 9.  Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.

Authors:  Chatchada Karanes; Gene O Nelson; Pintip Chitphakdithai; Edward Agura; Karen K Ballen; Charles D Bolan; David L Porter; Joseph P Uberti; Roberta J King; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

10.  High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.

Authors:  Meghan Delaney; Corey S Cutler; Richard L Haspel; Beow Y Yeap; Steven L McAfee; Bimalangshu R Dey; Eyal Attar; Grace Kao; Edwin P Alyea; John Koreth; Vincent T Ho; Susan Saidman; Deborah Liney; Doreen Sese; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin; Karen K Ballen
Journal:  Transfusion       Date:  2009-01-21       Impact factor: 3.157

View more
  29 in total

1.  Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.

Authors:  Kristjan Paulson; Ruta Brazauskas; Nandita Khera; Naya He; Navneet Majhail; Gorgun Akpek; Mahmoud Aljurf; David Buchbinder; Linda Burns; Sara Beattie; Cesar Freytes; Anne Garcia; James Gajewski; Theresa Hahn; Jennifer Knight; Charles LeMaistre; Hillard Lazarus; David Szwajcer; Matthew Seftel; Baldeep Wirk; William Wood; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2019-06-19       Impact factor: 5.742

2.  Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.

Authors:  Kavita Raj; Antonio Pagliuca; Kenneth Bradstock; Victor Noriega; Victoria Potter; Matthew Streetly; Donal McLornan; Majid Kazmi; Judith Marsh; John Kwan; Gillian Huang; Lisa Getzendaner; Stephanie Lee; Katherine A Guthrie; Ghulam J Mufti; Paul O'Donnell
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-18       Impact factor: 5.742

3.  Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.

Authors:  K Wadsworth; M Albrecht; R Fonstad; S Spellman; M Maiers; J Dehn
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

4.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 5.  Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.

Authors:  Mary Eapen; Paul O'Donnell; Claudio G Brunstein; Juan Wu; Kate Barowski; Adam Mendizabal; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-23       Impact factor: 5.742

6.  Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.

Authors:  Bronwen E Shaw
Journal:  Blood Adv       Date:  2017-02-14

7.  Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.

Authors:  Jun Zou; Stefan O Ciurea; Piyanuch Kongtim; Min Yi; Yudith Carmazzi; Gabriela Rondon; Samer Srour; David Partlow; Richard E Champlin; Kai Cao
Journal:  Blood Adv       Date:  2020-08-11

8.  Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

Authors:  Joseph Pidala; Tatenda G Mupfudze; Tammy Payton; Juliet Barker; Miguel-Angel Perales; Bronwen E Shaw; Marcelo Fernández-Viña; Linda J Burns; Jason Dehn
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-13       Impact factor: 5.742

Review 9.  Halfway there: the past, present and future of haploidentical transplantation.

Authors:  M Slade; B Fakhri; B N Savani; R Romee
Journal:  Bone Marrow Transplant       Date:  2016-07-25       Impact factor: 5.483

10.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.